Fingerprint
Dive into the research topics of 'Phase I trial of dihydrolenperone in lung cancer patients: A novel compound with in vitro activity against lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of dihydrolenperone in lung cancer patients: A novel compound with in vitro activity against lung cancer
Bruce E. Johnson, Robert Parker, C. M. Tsai, Julie Baltz, Mae Jean Miller, Robert Shoemaker, Ruby Phelps, Anne Bastian, Joyce Stocker, John Phares, James L. Mulshine, Adi F. Gazdar, Daniel C. Ihde
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations